Safety Shot, Inc. (SHOT) - Dilution Analysis

10-Q filing | 7.9M shares outstanding

S-3 filing: The company may offer and sell up to $100,000,000 in aggregate of common stock and preferred stock.

10-K filing | 7.9M shares outstanding

S-1/A filing: This is an S-1/A filing with information about the terms and conditions related to the offering of securities.

8-K filing: Stock split 1-for-35 | Outstanding: 185,476,283 → 5,285,037

S-1 filing: This prospectus relates to the resale or other disposition from time to time in one or more offerings of up to 31,839,533 shares of our common stock by the Selling Stockholders named herein.

10-Q filing | 184.0M shares outstanding

8-K filing: Safety Shot, Inc. amended and restated the conversion price of its Series C Preferred Stock, which resulted in a reduction in the number of common stock shares into which the Series C Preferred issued to an institutional investor and LetsBonk.fun can be converted.

8-K filing: Safety Shot, Inc. entered into a Securities Purchase Agreement for a PIPE offering of Series C Convertible Preferred Stock and a Revenue Sharing Agreement, both convertible into Common Stock, with issuances expected within five business days. ($25.0M proceeds)

8-K filing: Safety Shot, Inc. entered into a stock purchase agreement on July 14, 2025, selling 500,000 shares of SRM Entertainment, Inc. common stock to an institutional investor for $2,500,000. ($2.5M proceeds)

8-K filing: Safety Shot, Inc. sold 500,000 shares of SRM Entertainment, Inc. common stock to an institutional investor for $3,125,000. ($3.13M proceeds)

8-K filing: Safety Shot, Inc. amended a Securities Purchase Agreement to adjust the warrant exercise price and entered into an Exchange Agreement to exchange convertible notes for Series B Preferred Stock; they also filed a Certificate of Designation for Series B Convertible Preferred Stock.

8-K filing: Safety Shot, Inc. entered into a Securities Purchase Agreement with an accredited investor for the purchase of 844,594 shares at $0.296 per share, resulting in gross proceeds of $250,000. ($0.25M proceeds)

8-K filing: Safety Shot, Inc. entered into a Securities Purchase Agreement with one accredited investor for the purchase of 1,000,000 shares and exchanged 6,575,025 shares of Common Stock for 39,933 shares of Series A-1 Preferred Stock. ($0.25M proceeds)

8-K filing: Safety Shot, Inc. issued 1,157,407 shares of common stock to an accredited investor for gross proceeds of $250,000 and issued 7,275,915 shares of Common Stock to Silverback Capital Corporation in a settlement of outstanding liabilities. ($0.25M proceeds)

8-K filing: Safety Shot, Inc. amended its liabilities settlement program with Silverback Capital Corporation, modifying terms related to the closing price, valuation period, and minimum price floor, and issued 1,000,000 shares to SCC for legal and transaction fees.

S-1/A filing: Resale of 1,233,507 shares of common stock by selling stockholders.

S-1 filing: This prospectus relates to the resale or other disposition from time to time in one or more offerings of up to 1,233,507 shares of our common stock by the Selling Stockholders.

10-Q filing | 69.3M shares outstanding

8-K filing: Safety Shot, Inc. entered into a Securities Purchase Agreement with one accredited investor for the purchase of 641,000 shares at a negotiated price of $0.39 per share, resulting in gross proceeds of $250,000. ($0.25M proceeds)

8-K filing: Safety Shot, Inc. exchanged common stock and warrants for Series A Preferred Stock with Core 4 Capital Corp. and filed a Certificate of Designation for the Series A Preferred Stock.

S-1/A filing: This is an S-1/A filing related to a primary offering of securities, outlining the registrant's responsibilities regarding communications during the offering and indemnification for liabilities.

S-1/A filing: This prospectus relates to the resale of up to 23,885,404 shares of common stock by Selling Stockholders, including shares underlying convertible notes and warrants, and shares issued to Intracoastal Capital.

8-K filing: Safety Shot, Inc. issued 2,500,000 shares of restricted stock to Core 4 Capital Corp. as an amendment to a consulting agreement and 4,000,000 warrants at $0.125 per warrant. ($0.5M proceeds)

S-1/A filing: This prospectus relates to the resale of up to 23,885,404 shares of common stock by Selling Stockholders, including shares underlying convertible notes, warrants, and shares issued under settlement agreements.

10-K filing | 74.5M shares outstanding

8-K filing: Safety Shot, Inc. entered into a Securities Purchase Agreement with an accredited investor for the purchase of 3,500,000 shares at $0.368 per share, resulting in gross proceeds of $1,288,000. ($1.29M proceeds)

8-K filing: Safety Shot, Inc. entered into a Securities Purchase Agreement with an accredited investor for the purchase of 2,222,222 shares at $0.45 per share, resulting in gross proceeds of $1,000,000. ($1.0M proceeds)

8-K filing: Safety Shot, Inc. entered into a Securities Purchase Agreement with an investor for the purchase of 2,753,304 shares of common stock and 2,753,304 warrants for gross proceeds of $1,165,198.24. ($1.17M proceeds)

S-1 filing: This prospectus relates to the resale or other disposition from time to time in one or more offerings of up to 23,985,404 shares of our common stock by the Selling Stockholders named herein.

8-K filing: Safety Shot, Inc. sold 651,042 shares to one accredited investor for gross proceeds of $250,000 at a price of $0.3840 per share on January 29, 2025. ($0.25M proceeds)

8-K filing: Safety Shot, Inc. entered into a Consulting Agreement with Blue Capital S.A., LLC. to issue 4,545,454 options, a settlement agreement with Bigger Capital, LLC to issue 5,332,889 warrants, and will exchange 1,650,050 warrants held by Bigger Capital for 5,332,889 warrants.

8-K filing: Safety Shot, Inc. entered into a Securities Purchase Agreement with an accredited investor for the purchase of 2,277,389 shares at a price of $0.4391 per share for gross proceeds of $1,000,000. ($1.0M proceeds)

8-K filing: Safety Shot, Inc. entered into a definitive Arrangement Agreement to acquire all of the issued and outstanding common shares of Yerbaé Brands Corp. in consideration for 20,000,000 shares of Safety Shot's common stock.

10-Q filing | 55.9M shares outstanding

S-3/A filing: This S-3/A filing relates to the resale of up to 1,898,029 shares of common stock by the selling stockholder.

S-3/A filing: Resale of 1,898,029 shares of common stock by selling stockholder.

S-3/A filing: Resale of up to 1,898,029 shares of common stock by the selling stockholder.

S-3 filing: This S-3 filing relates to the resale of up to 1,898,029 shares of common stock by the selling stockholder, including shares issuable upon exercise of warrants.

8-K filing: Safety Shot, Inc. entered into a Securities Purchase Agreement for the sale of 448,029 shares at $1.12 per share and issued 1,250,000 shares to a consultant, and exchanged 100% of Caring Brands Florida for Caring Brands Nevada shares. ($0.5M proceeds)

8-K filing: Safety Shot, Inc. entered into a Securities Purchase Agreement to sell 3,370,787 shares and 3,370,787 warrants to an accredited investor at $0.89 per share and $0.125 per warrant, respectively, with expected net proceeds of approximately $3,421,348.

10-Q filing | 51.7M shares outstanding

8-K filing: Safety Shot, Inc. entered into a Securities Purchase Agreement with an accredited investor for the purchase of 943,396 shares at $1.06 per share, resulting in net proceeds of approximately $1,000,000. ($1.0M proceeds)

10-Q filing | 47.4M shares outstanding

8-K filing: Safety Shot, Inc. entered into an employment agreement with Danielle De Rosa, including an option to purchase 200,000 shares of common stock at an exercise price of $1.57.

8-K filing: Safety Shot, Inc. entered into a Securities Purchase Agreement for the purchase of 2,369,668 shares at a price of $2.11 per share, resulting in net proceeds of approximately $4,975,000. ($4.98M proceeds)

10-K filing | 49.2M shares outstanding

8-K filing: Safety Shot Inc. entered into a License and Purchase Agreement with Elite Health Partners Inc., granting them a license to use and potentially purchase assets related to the Company's over-the-counter health and wellness products in exchange for 4,000,000 shares of Licensee Common Stock.

POS AM filing: This prospectus relates to an aggregate of 12,049,792 shares of our common stock, par value $0.001 per share, upon the exercise of warrants.

POS AM filing: This prospectus relates to an aggregate of 12,049,792 shares of our common stock, par value $0.001 per share, upon the exercise of warrants.

POS AM filing: This prospectus relates to the offering of shares of common stock upon the exercise of outstanding warrants.

POS AM filing: This prospectus relates to an aggregate of 12,049,792 shares of our common stock, par value $0.001 per share, upon the exercise of the following warrants: (1) 11,607,142 warrants (the "Company Warrants") to purchase 11,607,142 shares (the "Company Warrant Shares") and (2) 442,650 warrants to the representative of the underwriters (the "Underwriter's Warrants," collectively with the Company Warrant, the "Warrant") to purchase 442,650 shares (the "Underwriter Warrant Shares," collectively with the Company Warrant Shares, the "Warrant Shares").

POS AM filing: Safety Shot, Inc. is offering 11,607,142 warrants and 442,650 underwriter's warrants, each exercisable for one share of common stock. The Company Warrants have an exercise price of $1.40 per share and the Underwriter Warrants have an exercise price of $3.50.

POS AM filing: This POS AM filing relates to the offering of warrants to purchase shares of common stock.

S-3 filing: This prospectus relates to the resale of up to 1,978,796 shares of common stock by the selling stockholder, including shares issuable upon exercise of warrants.

POS AM filing: This prospectus relates to an aggregate of 12,049,792 shares of our common stock upon the exercise of warrants.

S-3/A filing: This is an S-3/A filing for SAFETY SHOT, INC. related to the offering of warrants and shares of common stock.

10-Q filing | 39.8M shares outstanding

8-K filing: Safety Shot, Inc. issued 262,500 shares of its common stock to investors as incentive shares and adjusted the exercise price of warrants to $0.932 per share.

8-K filing: Jupiter Wellness, Inc. issued 5,000,000 common shares as part of an asset purchase agreement with GBB Labs, Inc.

8-K filing: Jupiter Wellness, Inc. consummated the separation from SRM Entertainment, Inc. on August 14, 2023, distributing 2,000,000 shares of SRM's common stock to its stockholders and warrant holders, and SRM completed its IPO of 1,250,000 shares of common stock at $5.00 per share. ($6.25M proceeds)

10-Q filing | 26.7M shares outstanding

8-K filing: Jupiter Wellness, Inc. entered into an asset purchase agreement with GBB Labs, Inc. to purchase assets relating to the Seller's business for $200,000 in cash and 5,000,000 common shares.

S-1/A filing: This prospectus relates to the sale of up to 8,631,574 shares of common stock issuable upon exercise of warrants by the selling shareholders.

S-1/A filing: This prospectus relates to the sale of up to 8,631,574 shares of common stock by selling shareholders, consisting of shares issuable upon exercise of warrants.

8-K filing: Jupiter Wellness, Inc. entered into an Amended and Restated Exchange Agreement with SRM Entertainment, Inc. to exchange all of the capital stock of SRM Entertainment LTD for 6,500,000 shares of SRM, with plans to spin off 2,000,000 shares of SRM to its stockholders and warrant holders and effect an initial public offering of SRM shares.

10-Q filing | 25.6M shares outstanding

S-1/A filing: This prospectus is a part of the registration statement relating to the sale or other disposition from time to time by the selling shareholders identified in this prospectus of up to 8,631,574 shares of common stock.

10-K filing | 26.7M shares outstanding

S-1 filing: This S-1 filing registers shares of common stock issuable upon the exercise of warrants by selling shareholders. Jupiter Wellness, Inc. will not receive any proceeds from the sale of these shares, but may receive proceeds from the exercise of the warrants.

8-K filing: Jupiter Wellness, Inc. issued 4,315,787 shares of common stock at $0.70 per share in a registered direct offering and issued warrants to purchase 8,631,574 shares of common stock in a private placement.

8-K filing: Jupiter Wellness, Inc. agreed to lower the exercise price of an aggregate of 1,460,000 warrants from $2.79 per share to $1.00 per share.

10-Q filing | 21.5M shares outstanding

S-3/A filing: The company may offer and sell up to $100,000,000 in aggregate of common stock and preferred stock.

S-3 filing: The company is offering and selling up to $100,000,000 in aggregate of common stock and preferred stock.

8-K filing: Jupiter Wellness, Inc. amended its Asset Purchase Agreement with Applied Biology Inc., altering the purchase price. Instead of 2,000,000 shares of restricted common stock, the aggregate purchase price is now $200,000.

10-Q filing | 21.9M shares outstanding

8-K filing: Jupiter Wellness, Inc. executive officers cancelled 2,750 options each and returned 56,496 shares of common stock issued to them in 2021 outside of a shareholder approved equity compensation plan.

8-K filing: Jupiter Wellness, Inc. closed an asset purchase agreement with Applied Biology Inc. to purchase all of the Seller's assets used in its business in exchange for up to 2,000,000 restricted shares of the Company's common stock.

S-3 filing: This prospectus relates to the resale or other disposition from time to time in one or more offerings of up to 6,830,538 shares of our common stock by the selling stockholder named herein.

10-Q filing | 23.1M shares outstanding

8-K filing: Jupiter Wellness, Inc. issued a convertible promissory note and warrants to Greentree for $1,500,000 and to L&H for $500,000, along with an aggregate of 250,000 shares of common stock.

10-K filing | 22.1M shares outstanding

8-K filing: Jupiter Wellness, Inc. will acquire all of the outstanding capital stock of Next Frontier Pharmaceuticals, Inc. in exchange for 500,000 shares of newly designated Company's Series B Preferred Stock, which is convertible into an aggregate of 65,000,000 shares of the Company's Common Stock.

10-Q filing | 23.3M shares outstanding

8-K filing: Jupiter Wellness, Inc. issued 60,000 shares of restricted common stock to Tee-2-Green Enterprises Limited as consideration for a two-year extension of their endorsement agreement.

10-Q filing | 22.9M shares outstanding

S-1/A filing: This is a firm commitment offering of shares of common stock and warrants by Jupiter Wellness, Inc. and shares of common stock by selling stockholders, with an option for the underwriter to purchase additional shares.

S-1 filing: This is a firm commitment offering of shares of common stock and warrants of Jupiter Wellness, Inc.

S-1/A filing: Jupiter Wellness, Inc. is offering (a) up to 525,001 shares of common stock issuable upon exercise of Warrants and (b) up to 525,001 shares of Common Stock issuable upon conversion of promissory notes.

S-1 filing: This prospectus relates to the sale or other disposition from time to time by the selling shareholders identified in this prospectus of up to 1,050,002 shares of Common Stock consisting of up to 525,001 Common Stock which may be issued upon the conversion of convertible promissory notes and up to 525,001 Common Stock which may be issued upon the exercise of outstanding warrants.

8-K filing: The company entered into two loan agreements, the May 24 Loan and the May 28 Loan, issuing convertible promissory notes and warrants for common stock.

10-Q filing | 11.2M shares outstanding

8-K filing: Jupiter Wellness, Inc. entered into a $2,500,000 Loan Agreement, issuing a Convertible Promissory Note and a Common Stock Purchase Warrant for 416,667 shares.

10-K filing | 10.7M shares outstanding

8-K filing: Jupiter Wellness, Inc. amends agreements with Krista Whitley, reducing the number of shares issuable upon exercise of common stock purchase options from 250,000 to 185,000, allowing for a cashless exercise feature subject to a six-month holding period, and limiting weekly sales to 10% of the Company's total weekly trading volume.

8-K filing: Jupiter Wellness, Inc. entered into an independent director's agreement with Ms. Nancy Torres Kaufman, issuing her options to purchase 20,000 shares of company common stock annually.

8-K filing: Jupiter Wellness, Inc. acquired 100% of the shares of SRM's common stock from the SRM Shareholders in exchange for 200,000 shares of the Company's common stock, with 150,000 shares delivered upon closing and 50,000 shares placed in escrow.

8-K filing: Jupiter Wellness, Inc. entered into an endorsement agreement with Tee-2-Green Enterprises Limited, issuing 50,000 shares of common stock and warrants to purchase 50,000 shares at $3.90 per share.

10-Q filing | 6.2M shares outstanding

8-K filing: Jupiter Wellness, Inc. completed an initial public offering of 933,333 units at $7.50 per unit, generating gross proceeds of approximately $7,000,000, and consummated the sale of 140,000 warrants at $0.01 per warrant, generating gross proceeds of $1,400. ($7.0M proceeds)

S-1/A filing: The company is offering 1,000,000 Units, each consisting of one share of common stock and one Warrant, each whole Warrant exercisable for one share of common stock at an assumed public offering price is US$7.50 per Unit.

S-1/A filing: The company is offering 1,000,000 Units, each consisting of one share of common stock and one Warrant at an assumed public offering price of US$7.50 per Unit.

S-1/A filing: This S-1/A filing describes an offering of 1,000,000 Units, each consisting of one share of common stock and one warrant, with an assumed public offering price of $7.50 per Unit.

S-1/A filing: This S-1/A filing outlines an offering of 1,000,000 Units, each consisting of one share of common stock and one Warrant, with an assumed public offering price of US$7.50 per Unit.

S-1/A filing: Jupiter Wellness, Inc. is offering 1,000,000 Units, each consisting of one share of common stock and one Warrant, each whole Warrant exercisable for one share of common stock at an assumed public offering price is US$7.50 per Unit.

S-1/A filing: Jupiter Wellness, Inc. is offering 1,000,000 Units, each consisting of one share of common stock and one Warrant, each whole Warrant exercisable for one share of common stock at an assumed public offering price is US$7.50 per Unit.

S-1/A filing: The company is offering 1,000,000 Units, each consisting of one share of common stock and one Warrant, each whole Warrant exercisable for one share of common stock at an assumed public offering price is US$7.50 per Unit.

S-1/A filing: Jupiter Wellness, Inc. is offering 1,000,000 Units, each consisting of one share of common stock and one warrant at an assumed public offering price is US$7.50 per Unit.

S-1 filing: This S-1 filing is for an offering of 1,000,000 Units, each consisting of one share of common stock and one warrant, at an assumed price of $7.50 per Unit. The company intends to apply to list its common stock and Warrants on the Nasdaq Capital Market under the symbols "JUPW" and "JUPWW".